<- Go Home
T&L Co., Ltd.
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.
Market Cap
KRW 585.2B
Volume
131.3K
Cash and Equivalents
KRW 60.7B
EBITDA
KRW 60.9B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
KRW 75.4B
Profit Margin
43.10%
52 Week High
KRW 85.6K
52 Week Low
KRW 50.4K
Dividend
N/A
Price / Book Value
3.41
Price / Earnings
12.61
Price / Tangible Book Value
3.49
Enterprise Value
KRW 510.5B
Enterprise Value / EBITDA
8.39
Operating Income
KRW 57.0B
Return on Equity
30.84%
Return on Assets
20.99
Cash and Short Term Investments
KRW 75.2B
Debt
KRW 452.3M
Equity
KRW 171.4B
Revenue
KRW 174.9B
Unlevered FCF
KRW 21.0B
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium